Clinical Trial on the Use of Cell Therapy in the Treatment of Patients With Amyotrophic Lateral Sclerosis (TCIM-ELAII)

2023-506215-17-00 Protocol IMB-TCIM/ELA II-2019 Therapeutic exploratory (Phase II) Ongoing, recruiting

Start 3 May 2021 · Status Ongoing, recruiting · 1 EU/EEA countries · 2 sites · Protocol IMB-TCIM/ELA II-2019

Overview

Sponsor-declared trial summary

Phase Therapeutic exploratory (Phase II)
Status Ongoing, recruiting
Participants planned 100
Countries 1
Sites 2

Amyotrophic Lateral Sclerosis

Key facts

Sponsor
Fundacion Para La Formacion E Investigacion Sanitaria De La Region De Murcia
Participant type
Patients
Age range
18-64 years, 65+ years
Gender
Male and Female
Therapeutic area
Diseases [C] - Musculoskeletal Diseases [C05]
Trial duration
3 May 2021 → ongoing
Decision date (initial)
2024-11-05
Transition trial
Yes
Low-intervention
No
Rare-disease indication
Yes
Vulnerable population
No

External identifiers

EU CT number
2023-506215-17-00
EudraCT number
2019-002302-46
ClinicalTrials.gov
NCT04849065

Trial design

CTIS Part I — objectives, methods, condition coding

Conditions and MedDRA coding

Amyotrophic Lateral Sclerosis

VersionLevelCodeTermSystem organ class
21.1 PT 10002026 Amyotrophic lateral sclerosis 100000004852

Sponsors and contacts

Sponsor organisations, regulatory contacts, third parties

Fundacion Para La Formacion E Investigacion Sanitaria De La Region De Murcia

Sponsor organisation
Fundacion Para La Formacion E Investigacion Sanitaria De La Region De Murcia
Address
Carretera De Cartagena S/n, El Palmar El Palmar
City
Murcia
Postcode
30120
Country
Spain

Scientific contact point

Organisation
Fundacion Para La Formacion E Investigacion Sanitaria De La Region De Murcia
Contact name
Maria

Public contact point

Organisation
Fundacion Para La Formacion E Investigacion Sanitaria De La Region De Murcia
Contact name
Maria

Locations

1 EU/EEA country · 2 investigational sites

By country

CountryMS statusPlanned subjectsSites
Spain Ongoing, recruiting 100 2
Rest of world 0

Investigational sites

Spain

2 sites · Ongoing, recruiting
Hospital General Universitario Dr. Balmis
Neurology, Avinguda Del Pintor Baeza 12, 03010, Alicante
University Clinical Hospital Virgen De La Arrixaca
Hematology, Carretera De Cartagena Sn, El Palmar, Murcia

Country notifications

Trial-start, recruitment-start, end and early-termination notifications submitted per Member State

Country Trial startTrial end Recruitment startRecruitment end Early termination
Spain 2021-05-03 2021-05-03

Application history

1 submissions — initial application plus substantial / non-substantial modifications

#TypeCodeSubmittedReference MSConclusionDecision date
1 INITIAL IN 2024-10-08 Spain Acceptable
2024-11-05
2024-11-05